{
  "docId": "019de074-05b7-71fd-bc3c-27f1b7be8924",
  "docSlug": "c3cb552ef3a6b077a714c97117e1fe86",
  "documentTitle": "Mink Therapeutics | Investor Day Presentation Deck | 92 slides",
  "authorId": "mink-therapeutics",
  "authorName": "MiNK Therapeutics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 35,
  "pageCount": 92,
  "prevPage": 34,
  "nextPage": 36,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "overcrowded",
  "nDataPoints": 24,
  "notes": "The slide presents clinical trial safety data including a table of adverse events and dot plots for inflammatory markers.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-05b7-71fd-bc3c-27f1b7be8924/35",
  "deckHref": "/decks/019de074-05b7-71fd-bc3c-27f1b7be8924",
  "deckJsonHref": "/decks/019de074-05b7-71fd-bc3c-27f1b7be8924.json",
  "deckAnchorHref": "/decks/019de074-05b7-71fd-bc3c-27f1b7be8924#slide-35",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.41,
        "x": 0.53,
        "y": 0.19
      },
      "kind": "callout",
      "text": "No Cytokine Release Syndrome or Neurotoxicity",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a61e1f47-a657-4bb7-a304-5d39a9e99d79",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.41,
        "x": 0.06,
        "y": 0.19
      },
      "kind": "callout",
      "text": "No DLTs and Few Related AEs",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "baa04656-fdfa-48d5-b60c-3be431d5a595",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.41,
        "x": 0.53,
        "y": 0.35
      },
      "kind": "chart",
      "text": "IL-1b, IL-6, and CRP levels over time",
      "attrs": null,
      "subkind": "dot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cdb7b121-970f-4e8f-aeda-467b2a492556",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.41,
        "x": 0.06,
        "y": 0.75
      },
      "kind": "list",
      "text": "Solid tumors: one TRAE of grade ≥3 (anemia); Multiple myeloma: TEAEs of grade ≥3 were observed in 2 subjects (thrombocytopenia); Most common TEAEs were fatigue, nausea, constipation, dizziness, anemia",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e359861d-d6a6-41e9-8189-894d70854414",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.25,
        "x": 0.6,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Stevens et al, SITC 2022, Poster 649",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9f5a3d8d-3360-443b-9514-4f2fb227649d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.41,
        "x": 0.06,
        "y": 0.28
      },
      "kind": "table",
      "text": "Multiple Myeloma (n=12) safety table",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5915e4b6-8193-483e-8eb3-9c222d13808c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.7,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "agenT-797 Administered Without Lymphodepletion in MM with a Favorable Safety Profile",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9e41edbf-85f2-4c66-a755-c11138046e60",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "03eb5583-0572-4abe-8be2-8ad73fae84bb",
      "evidence": "table/data: Multiple Myeloma (n=12) safety table",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 35,
      "from": 23,
      "beatId": "3ca2588f-ae86-4809-9434-ea06292b2cdd",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Evidence",
      "beatSlug": "evidence",
      "evidence": "The presentation provides preclinical and clinical data supporting iNKT cells' potential",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 35,
      "from": 23,
      "name": "Before After",
      "slug": "21-before-after",
      "bestFor": "Product demos, process improvements, ROI justification",
      "matchId": "d3a14978-bf9f-4a75-b0e8-87c8ef56ddbf",
      "evidence": "The presentation uses before-after comparisons to show iNKT cells' potential",
      "position": 1,
      "objective": "Illustrating the benefits of iNKT cells",
      "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta",
      "confidence": 0.7,
      "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}